Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Spontaneously immunogenic hepatocellular carcinoma (HCC), identified by a dense immune cell infiltrate (ICI), responds better to immunotherapy, although no validated biomarker exists to identify these cases. We used machine learning (ML) to quantify ICI from standard H&E-stained tissue and evalu...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMJ Publishing Group
2025-10-01
|
| Seria: | Journal for ImmunoTherapy of Cancer |
| Dostęp online: | https://jitc.bmj.com/content/13/10/e010975.full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
